Shane Gray suspended following positive Sample A result

The National Rugby League has, after consultation with the Manly Sea Eagles, imposed a provisional suspension effective immediately upon Manly Under 20’s player Shane Gray over a positive drug test result to Clenbuterol.

The NRL is not in a position to give any further detail in relation to the test, which is still at the ‘A’ Sample stage.

Under both the World Anti-Doping Authority Code and the NRL Anti Doping Policy, a player is subject to a provisional suspension upon notification of the ‘A’ Sample.

A player has the right to be represented at the testing of his ‘B’ sample and will be advised by the Australian Sports Anti Doping Authority when that test will take place.

Should the ‘B’ sample test not confirm the result, the matter would not be pursued.

Should the ‘B’ Sample test confirm the result the player will be offered a ‘submission period’ of up to ten days through the Australian Sports Anti Doping Authority to raise concerns over the testing procedures. At the conclusion of this process the result may be posted on ASADA’s Register of Notifiable Events.

The NRL can issue an infraction notice once a ‘B sample’ is confirmed but may also wait until the ASADA submission period is concluded. This can depend significantly on a player’s wish to have an ‘expedited hearing’ before the NRL Drugs Tribunal. Once the NRL has issued an infraction notice a player can either accept the penalty outlined in that notice or seek a hearing before the NRL Drugs Tribunal.

The Tribunal consists of a: legally qualified medical practitioner, a person qualified as barrister or solicitor, and a prominent citizen.

Note: Clenbuterol is prohibited both in and out of competition under the World Anti-Doping Code 2009 Prohibited List S1 (2). A finding of a doping offence in relation to the use of this substance would see an athlete face a two-year penalty subject only to that athlete arguing a reduction through the ameliorating provisions within the policy including ‘No Significant Fault or Negligence’ clauses or through providing substantial assistance in ‘Discovering or Establishing Anti-Doping Rule Violations’.